Role of "western diet" in inflammatory autoimmune diseases

Current Allergy and Asthma Reports

Volumn 14, Issue 1, 2014, Pages

  Manzel, Arndt ^a   Muller, Dominik N ^b   Hafler, David A ^c,d   Erdman, Susan E ^e   Linker, Ralf A ^a   Kleinewietfeld, Markus ^c,d,f  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Autoimmune diseases; Autoimmunity; Gut microbiome; Inflammatory; Obesity; Sodium; T cell regulation; Western diet

Indexed keywords

ANIMAL; AUTOIMMUNE DISEASES; COMORBIDITY; DIET; FEEDING BEHAVIOR; HELPER CELL; HUMAN; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; LIFESTYLE; MICROFLORA; OBESITY; AUTOIMMUNE DISEASE; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; COMORBIDITY; DIET; FOOD HABITS; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; LIFE STYLE; MICROBIOTA; OBESITY; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84894363156     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-013-0404-6     Document Type: Article

References (100)

1. Sawcer S et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476(7359):214-9. Comprehensive analysis of genetic risk factors for multiple slerosis.
2. Cotsapas C, Hafler DA. Immune-mediated disease genetics: the shared basis of pathogenesis. Trends Immunol. 2013;34(1):22-6.
3. Bogdanos DP et al. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun. 2012;38(2-3):J156-69.
4. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911-20.
5. Okada H et al. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol. 2010;160(1):1-9.
6. Svenningsson A et al. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurol Scand. 1990;82(3):161-8.
7. Cook SD et al. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology. 1985;35(4):545-51.
8. Elhami SR et al. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology. 2011;36(3):141-7.
9. Houzen H et al. Increasing prevalence and incidence of multiple sclerosis in northern Japan. Mult Scler. 2008;14(7):887-92.
10. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003;2(2):117-27.
11. Yamamoto T, Nakahigashi M, Saniabadi AR. Review article: diet and inflammatory bowel disease - epidemiology and treatment. Aliment Pharmacol Ther. 2009;30(2):99-112.
12. Rook GA. Hygiene hypothesis and autoimmune diseases. Clin Rev Allergy Immunol. 2012;42(1):5-15.
13. Rapaport B, Karceski S. Multiple sclerosis and stress. Neurology. 2012;79(5):e47-9.
14. Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus. 2006;15(11):737-45.
15. Hernan MA, Olek MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol. 2001;154(1):69-74.
16. Brantley PJ, Myers VH, Roy HJ. Environmental and lifestyle influences on obesity. J La State Med Soc. 2005;157(Spec No 1):S19-27.
17. Landsberg L et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment - a position paper of the The Obesity Society and The American Society of Hypertension. Obesity (Silver Spring). 2013;21(1):8-24.
18. Procaccini C et al. Obesity and susceptibility to autoimmune diseases. Expert Rev Clin Immunol. 2011;7(3):287-94.
19. Schwarz S, Leweling H. Multiple sclerosis and nutrition. Mult Scler. 2005;11(1):24-32.
20. Cashman KD, Shanahan F. Is nutrition an aetiological factor for inflammatory bowel disease? Eur J Gastroenterol Hepatol. 2003;15(6):607-13.
21. Aho K, Heliovaara M. Risk factors for rheumatoid arthritis. Ann Med. 2004;36(4):242-51.
22. Andersen V et al. Diet and risk of inflammatory bowel disease. Dig Liver Dis. 2012;44(3):185-94.
23. Virtanen SM et al. Food consumption and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes: a nested case-control design. Am J Clin Nutr. 2012;95(2):471-8.
24. Norris JM et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA. 2007;298(12):1420-8.
25. Agranoff BW, Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet. 1974;2(7888):1061-6.
26. Esparza ML, Sasaki S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am J Epidemiol. 1995;142(7):733-7.
27. Lauer K. The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study. J Clin Epidemiol. 1994;47(1):43-8.
28. Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology. 2009;73(19):1543-50.
29. Hedstrom AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler. 2012;18(9):1334-6.
30. Swank RL et al. Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. N Engl J Med. 1952;246(19):722-8.
31. Ricketts JR, Rothe MJ, Grant-Kels JM. Nutrition and psoriasis. Clin Dermatol. 2010;28(6):615-26.
32. Naldi L et al. Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br J Dermatol. 1996;134(1):101-6.
33. Phillips CM. Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients. 2013;5(1):32-57.
34. Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev. 2006;27(7):750-61.
35. Ono T, Guthold R, Strong K. WHO Global Comparable Estimates. https://apps.who.int/infobase/; 2005.
36. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-7.
37. Sterry W, Strober BE, Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol. 2007;157(4):649-55.
38. Ferraz-Amaro I et al. Metabolic syndrome in rheumatoid arthritis. Mediat Inflamm. 2013;2013:710928.
39. Chung CP et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008;196(2):756-63.
40. Mijac DD et al. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med. 2010;21(4):315-9.
41. Delgado-Aros S et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004;99(9):1801-6.
42. Desreumaux P et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology. 1999;117(1):73-81.
43. Ouchi N et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85-97.
44. Winer S et al. Obesity predisposes to Th17 bias. Eur J Immunol. 2009;39(9):2629-35.
45. Poutahidis T et al. Microbial reprogramming inhibits Western diet-associated obesity. PLoS ONE. 2013;8(7):e68596. Study demonstrating that probiotic bacteria can prevent obesity in a Treg-dependent manner.
46. Cipolletta D et al. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 2012;486(7404):549-53.
47. Cipolletta D et al. Tissular T(regs): a unique population of adipose-tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism. Semin Immunol. 2011;23(6):431-7. Comprehensive review on fat-residing Tregs.
48. Sumarac-Dumanovic M et al. Increased activity of interleukin-23/ interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond). 2009;33(1):151-6.
49. Ahmed M, Gaffen SL. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev. 2010;21(6):449-53.
50. Paik J et al. High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-/- male mice. J Nutr. 2013;143(8):1240-7.
51. Jhun JY et al. Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation. Exp Mol Med. 2012;44(7):424-31.
52. Timmermans S, et al. High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the renin angiotensin system. J NeuroImmune Pharmacol. 2013. doi: 10.1007/s11481-013-9502-4.
53. Sanna V et al. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest. 2003;111(2):241-50.
54. Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J Leukoc Biol. 2008;84(4):940-8.
55. Unoda K et al. Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol. 2013;256(1-2):7-12.
56. Sanchez-Fidalgo S et al. Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice. J Nutr Biochem. 2013;24(7):1401-13.
57. Leslie CA et al. A fish oil diet reduces the severity of collagen induced arthritis after onset of the disease. Clin Exp Immunol. 1988;73(2):328-32.
58. Aktas O et al. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J Immunol. 2004;173(9):5794-800.
59. Wu C et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature. 2013;496(7446):513-7. Experimental work on a new salt-sensitive pathway in the control of Th17 responses.
60. Kleinewietfeld M et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature. 2013;496(7446):518-22. First study to show an influence of high-salt on human and murine Th17 differentiation and of high-salt diet on EAE severity.
61. Okada Y, et al. Trans fatty acids exacerbate DSS-induced colitis by promoting the upregulation of macrophage-derived proinflammatory cytokines involved in T helper 17 cell polarization. Clin Exp Immunol. 2013.
62. Pond CM. Paracrine relationships between adipose and lymphoid tissues: implications for the mechanism of HIV-associated adipose redistribution syndrome. Trends Immunol. 2003;24(1):13-8.
63. Matarese G et al. Leptin as a metabolic link to multiple sclerosis. Nat Rev Neurol. 2010;6(8):455-61.
64. De Rosa V et al. Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J Clin Invest. 2006;116(2):447-55.
65. Brown IJ et al. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38(3):791-813.
66. Savica V, Bellinghieri G, Kopple JD. The effect of nutrition on blood pressure. Annu Rev Nutr. 2010;30:365-401.
67. Bragulat E, de la Sierra A. Salt intake, endothelial dysfunction, and salt-sensitive hypertension. J Clin Hypertens (Greenwich). 2002;4(1):41-6.
68. Guzik TJ et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204(10):2449-60.
69. Kvakan H et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation. 2009;119(22):2904-12.
70. Klack K, Bonfa E, Borba Neto EF. Diet and nutritional aspects in systemic lupus erythematosus. Rev Bras Reumatol. 2012;52(3):384-408.
71. Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci U S A. 1995;92(26):12230-4.
72. Junger WG et al. Hypertonic saline enhances cellular immune function. Circ Shock. 1994;42(4):190-6.
73. Loomis WH et al. Hypertonicity rescues T cells from suppression by trauma-induced anti-inflammatory mediators. Am J Physiol Cell Physiol. 2001;281(3):C840-8.
74. Go WY et al. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc Natl Acad Sci U S A. 2004;101(29):10673-8.
75. Kino T et al. Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal. 2009;2(57):ra5.
76. Woehrle T et al. Hypertonic stress regulates T cell function via pannexin-1 hemichannels and P2X receptors. J Leukoc Biol. 2010;88(6):1181-9.
77. Titze J. Water-free sodium accumulation. Semin Dial. 2009;22(3):253-5.
78. Machnik A et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009;15(5):545-52.
79. Wiig H et al. Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest. 2013;123(7):2803-15. Study demonstrating salt-dependent effects on macrophages in vivo.
80. Rakova N et al. Long-term space flight simulation reveals infradian rhythmicity in human na(+) balance. Cell Metab. 2013;17(1):125-31. Long-term study on salt intake in humans under highly controlled conditions.
81. Marchesi J, Shanahan F. The normal intestinal microbiota. Curr Opin Infect Dis. 2007;20(5):508-13.
82. Kau AL et al. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474(7351):327-36. Comprehensive review on nutrition factors, intestinal microbiota, and immune responses.
83. Hildebrandt MA, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137(5):1716-24 e1-2.
84. Hormannsperger G, Haller D. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease. Int J Med Microbiol. 2010;300(1):63-73.
85. Maccaferri S, Biagi E, Brigidi P. Metagenomics: key to human gut microbiota. Dig Dis. 2011;29(6):525-30.
86. Turnbaugh PJ et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480-4.
87. Qin J et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55-60.
88. Morgan XC et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13(9):R79.
89. Berer K et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538-41. Experimental study linking microbiota to neuroinflammation.
90. Tlaskalova-Hogenova H et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011;8(2):110-20.
91. Lavasani S et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE. 2010;5(2):e9009.
92. Lee YK et al. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4615-22. Experimental study linking microbiota to neuroinflammation.
93. Atarashi K et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331(6015):337-41. Study showing the induction of Tregs by specific bacteria.
94. Atarashi K et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500(7461):232-6. First study showing the induction of functional Tregs by a selected set of human bacteria.
95. Esplugues E et al. Control of TH17 cells occurs in the small intestine. Nature. 2011;475(7357):514-8. Study on intestinal control of Th17 responses.
96. Gomez-Vaquero C et al. Nutritional status in patients with rheumatoid arthritis. Joint Bone Spine. 2001;68(5):403-9.
97. Giugliano D, Esposito K. Mediterranean diet and metabolic diseases. Curr Opin Lipidol. 2008;19(1):63-8.
98. Torkildsen O et al. Omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol. 2012;69(8):1044-51.
99. van Nood E et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407-15.
100. Weinstock JV. Autoimmunity: the worm returns. Nature. 2012;491(7423):183-5.